Completed NA INTERVENTIONAL 2-arm NCT01214928

Hemodialysis Vitamin D Pilot

Oral Cholecalciferol (Vitamin D3) Therapy in Prevalent Hemodialysis Patients: A Randomized Placebo Controlled Pilot Study

Sponsor: St. Joseph's Healthcare Hamilton

Conditions Renal Failure Chronic Requiring Hemodialysis Vitamin D Deficiency

Interventions Cholecalciferol

Updated 5 times since 2017 Last updated: Jul 19, 2011 Started: Jan 31, 2011 Primary completion: May 31, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Renal Failure Chronic Requiring Hemodialysis and Vitamin D Deficiency and is currently completed. St. Joseph's Healthcare Hamilton leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Joseph's Healthcare Hamilton
The Physicians' Services Incorporated Foundation

Data source: St. Joseph's Healthcare Hamilton

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada